POUKALOV KONSTANTIN purchased 1.7% of their position (250.19K shares) of LANDOS BIOPHARMA, INC. on the open market
Open‑market purchase worth $3.21M — a small addition. The strongest form of insider conviction signal.
P · 6 purchases
Filed: 2/9/2021ACC: 0001209191-21-009047
Director10% Owner
Since Feb 2021
+250.19K
Net shares
Net buyer
$3.21M
Total acquired
6
Open market trades
6B · 0S
6
Total transactions
250.19K acquired
Non-Derivative Transactions6
Common Stock
Indirect
Shares
+27.45K
Price / share
$11.14
Trade value
$305.83K
% of position
0.2%
2/5/2021
14.62M→14.65M
Common Stock
Indirect
Shares
+34.61K
Price / share
$11.38
Trade value
$393.87K
% of position
0.2%
2/8/2021
14.65M→14.68M
Common Stock
Indirect
Shares
+86.67K
Price / share
$12.53
Trade value
$1.09M
% of position
0.6%
2/8/2021
14.68M→14.77M
Common Stock
Indirect
Shares
+1.77K
Price / share
$13.10
Trade value
$23.20K
% of position
0.0%
2/8/2021
14.77M→14.77M
Common Stock
Indirect
Shares
+64.73K
Price / share
$13.80
Trade value
$893.27K
% of position
0.4%
2/9/2021
14.77M→14.83M
Common Stock
Indirect
Shares
+34.95K
Price / share
$14.60
Trade value
$510.28K
% of position
0.2%
2/9/2021
14.83M→14.87M
Total
Net shares
+250.19K
Net value
$3.21M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/5/2021 | P · Purchase | +27.45K | $11.14 | $305.83K | 0.2% | 14.62M | 14.65M |
| Common Stock Indirect | 2/8/2021 | P · Purchase | +34.61K | $11.38 | $393.87K | 0.2% | 14.65M | 14.68M |
| Common Stock Indirect | 2/8/2021 | P · Purchase | +86.67K | $12.53 | $1.09M | 0.6% | 14.68M | 14.77M |
| Common Stock Indirect | 2/8/2021 | P · Purchase | +1.77K | $13.10 | $23.20K | 0.0% | 14.77M | 14.77M |
| Common Stock Indirect | 2/9/2021 | P · Purchase | +64.73K | $13.80 | $893.27K | 0.4% | 14.77M | 14.83M |
| Common Stock Indirect | 2/9/2021 | P · Purchase | +34.95K | $14.60 | $510.28K | 0.2% | 14.83M | 14.87M |
| Total | +250.19K | $3.21M | ||||||
Derivative Transactions0
No derivative transactions reported